The worldwide adoption of enhanced endoscopic imaging in diagnosis and treatment of non-muscle invasive bladder cancer (NMIBC): snapshot analysis from a global survey
Abbas Basiri, Guohua Zeng(First Affiliated Hospital of Guangzhou Medical University), Shingai B.A. Mutambirwa, Yasser Farahat(Shaikh Khalifa Medical City), Mohamed S. Al‐Marhoon, Ingrid Perscky, Athanasios Dellis, Thiago Camelo Mourão, V. Estrade, Marie‐Claire Rassweiler‐Seyfried, Liping Xie(First Affiliated Hospital Zhejiang University), Rahim Horuz(Istanbul Medipol University), Wen‐Jeng Wu(Kaohsiung Medical University), Víctor Cavadas, Mehmet Koçak(Istanbul Medipol University), R. Keshavamurthy(Christ University), Mohamad Moussa(Lebanese University), Peter Ka‐Fung Chiu(Chinese University of Hong Kong), Sung Kyu Hong(Seoul National University Bundang Hospital), Besut Daryanto, Teng Aik Ong(University of Malaya), Mohamed Jalloh(Cheikh Anta Diop University), Piotr Chłosta, Pilar Laguna(Istanbul Medipol University), Nibbras I. AL-Hamdani, Takahiro Yasui(Nagoya City University), Ranan Dasgupta, В. Н. Павлов(Bashkir State Medical University), Paksi Satyagraha, Jean de la Rosette(Radboud University Nijmegen), Hans Peter Schmid(Karlsruhe Institute of Technology), Selami Albayrak(Istanbul Medipol University), Ateş Kadıoğlu, Madhu Agrawal(Institute of Mental Health and Hospital), Norio Nonomura(Osaka City University), Nguyen Phuc Cam Hoang, Tania González León, Raed A. Azhar, Mumtaz Ahmad, Karin Marise Jaeger Anzolch, Vineet Gauhar(European Association of Urology), Vincenzo Ficarra(University of Padua), Bülent Erkurt, Andreas Neisius(Trier University of Applied Sciences), F. Gonzalez, А Г Мартов(Moscow City Hospital No 29)
Cited by 0
Related Papers
Noninvasive Detection of Clinically Occult Lymph-Node Metastases in Prostate Cancer
|New England Journal of Medicine|2003|2k
The Clinical Research Office of the Endourological Society Percutaneous Nephrolithotomy Global Study: Indications, Complications, and Outcomes in 5803 Patients
|Journal of Endourology|2011|818
The Lancet Commission on prostate cancer: planning for the surge in cases
|The Lancet|2024|694